Notably, tissue samples obtained using this technique can undergo tests for epidermal growth factor receptor (EGFR) mutations and immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in patients with non-small cell lung cancer (NSCLC). This evidence concerns the gene EGFR and non-small cell lung carcinoma.